TotalMarketCap

Insmed

INSMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$23.860 B

$108.76 -1.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Insmed (INSM) has a market capitalization of $23.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$606.4M

#1797 by revenue

Earnings

-$1.28B

Loss-making

Shares outstanding

219,380,309

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #21Roivant SciencesROIV$26.5B
  2. #22United TherapeuticsUTHR$24.1B
  3. #23InsmedINSM$23.9B
  4. #24ViatrisVTRS$21.8B
  5. #25Alnylam PharmaceuticalsALNY$21.0B

What if Insmed were worth as much as…

Open the what-if tool →

Gold $28.2T

$128,711.98

Per share 1,183× higher

Bitcoin $1.53T

$6,964.38

Per share 64.0× higher

Apple $5.02T

$22,863.41

Per share 210× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Insmed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.